Creo Medical Group Plc

(LSE) CREO

Current Price$12.82

Market Cap$5.36B

Since IPO (2016)-84%

5 Year-94%

1 Year+22%

1 Month+19%

Creo Medical Group Plc Financials at a Glance

Market Cap

$5.36B

Revenue (TTM)

$48.20M

Net Income (TTM)

$17.10M

EPS (TTM)

$0.00

P/E Ratio

-2.17

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$12.82

Volume

789,449

Open

$12.79

Price

$12.82

Volume

789,449

Open

$12.79

Previous Close

$13.10

Daily Range

$12.37 - $13.25

52-Week Range

$9.75 - $18.50

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$12.82

Volume

789,449

Open

$12.79

Previous Close

$13.10

Daily Range

$12.37 - $13.25

52-Week Range

$9.75 - $18.50

CREO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Creo Medical Group Plc

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

141

CEO

Craig Jonathan Gulliford

Website

www.creomedical.com

Headquarters

Chepstow, NP16 5UH, GB

CREO Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

-5%

Net Income Margin

Return on Equity

Return on Capital

-16%

Return on Assets

25%

Earnings Yield

-46.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.36B

Shares Outstanding

412.47M

Volume

789.45K

Avg. Volume

762.38K

Financials (TTM)

Gross Profit

$1.90M

Operating Income

$28.80M

EBITDA

$26.10M

Operating Cash Flow

$22.20M

Capital Expenditure

$400.00K

Free Cash Flow

$22.60M

Cash & ST Invst.

$8.70M

Total Debt

$4.40M

Creo Medical Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$2.20M

-83.7%

Gross Profit

$1.00M

-79.6%

Gross Margin

45.45%

N/A

Market Cap

$5.36B

N/A

Market Cap/Employee

$19.29M

N/A

Employees

278

N/A

Net Income

$16.90M

+225.2%

EBITDA

$9.50M

+27.5%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$16.30M

-5.8%

Accounts Receivable

$3.40M

-76.7%

Inventory

$3.20M

-60.0%

Long Term Debt

$1.90M

-66.1%

Short Term Debt

$2.30M

-36.1%

Return on Assets

24.56%

N/A

Return on Invested Capital

-15.92%

N/A

Free Cash Flow

$15.30M

+199.4%

Operating Cash Flow

$15.30M

+202.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPEC.LINSPECS Group plc

SPEC.LINSPECS Group plc$83.14-0.43%

HVO.LhVIVO plc

HVO.LhVIVO plc$7.30-2.67%

KOO.LKooth plc

KOO.LKooth plc$127.15-1.05%

HEMO.LHemogenyx Pharmaceuticals Plc

HEMO.LHemogenyx Pharmaceuticals Plc$660.00-2.22%

IHC.LInspiration Healthcare Group plc

IHC.LInspiration Healthcare Group plc$29.40+0.00%

IMM.LImmuPharma plc

IMM.LImmuPharma plc$4.16+2.83%

NCYT.LNovacyt S.A.

NCYT.LNovacyt S.A.$27.41-7.25%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.11+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.99+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.48-0.02%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.84+0.01%

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF$100.41-0.00%

JBLUJetBlue Airways

JBLUJetBlue Airways$4.97+0.07%

Questions About CREO

What is the current price of Creo Medical Group Plc?

Creo Medical Group Plc is trading at GBX 12.82 per share.

What is the 52-week range for Creo Medical Group Plc?

Over the past 52 weeks, Creo Medical Group Plc has traded between GBX 9.75 and GBX 18.50.

How much debt does Creo Medical Group Plc have?

As of the most recent reporting period, Creo Medical Group Plc reported total debt of $4.40M.

How much cash does Creo Medical Group Plc have on hand?

Creo Medical Group Plc reported $8.70M in cash and cash equivalents in its most recent financial results.

What is Creo Medical Group Plc’s dividend yield?

Creo Medical Group Plc does not currently have a dividend yield.

Creo Medical Group Plc

Creo Medical Group Plc Financials at a Glance

CREO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Creo Medical Group Plc

CREO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Creo Medical Group Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CREO

What is the current price of Creo Medical Group Plc?

What is the 52-week range for Creo Medical Group Plc?

How much debt does Creo Medical Group Plc have?

How much cash does Creo Medical Group Plc have on hand?

What is Creo Medical Group Plc’s dividend yield?

Premium Investing Services